Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654925 · ClinicalTrials.gov registry record
Myeloid to Adipocyte Transdifferentiation in Human Cells
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 59
- Enrollment target
NCT02654925: Completed study, sponsored by University of Colorado, Denver.
NCT02654925 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02654925 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 59 participants
- Enrollment target
Study Summary
In order to design new programs to help prevent weight gain, promote successful and sustainable weight loss, and help treat diseases related to obesity, the investigators need a better understanding of why accumulating fat in certain regions of the body is bad for health. It is known that not all fat cells are the same, but it was recently discovered that some fat cells may arise from stem cells that come from the bone marrow (bone marrow progenitors), a previously unrecognized origin. This discovery has been paradigm shifting, because dogma has long held that all white fat cells arise from fat tissue resident mesenchymal stem cells. This is also important because fat cells arising from the bone marrow lineage may be linked to worse health outcomes. The aim of this study is to determine if cells that were not previously believed to contribute to fat generation in humans are indeed capable of becoming fat cells. To answer this question the investigators will take samples of cells from the blood and the fat tissue of younger and older men and women, isolate the cells that came from the bone marrow and grow them in culture to determine if they will turn into fat cells. The results of this investigation may reveal potential mechanistic targets for future therapies to reduce the negative health outcomes associated with obesity related chronic diseases.
Interventions
- PROCEDURE Adipose Tissue Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2016-03 |
| Est. Completion | 2021-06-15 |
What the finished NCT02654925 record still lists
NCT02654925 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adipose Tissue Biopsy is the first listed.
NCT02654925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02654925 about?
NCT02654925 is a clinical study titled "Myeloid to Adipocyte Transdifferentiation in Human Cells". In order to design new programs to help prevent weight gain, promote successful and sustainable weight loss, and help treat diseases related to obesity, the investigators need a better understanding of why accumulating fat in certain regions of the body is bad for health. It is known that not all fa...
What is the current status of trial NCT02654925?
This trial is currently completed. The enrollment target is 59 participants. The study started on 2016-03. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT02654925?
The interventions under investigation include: Adipose Tissue Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02654925?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia